Is a 0.7 cm non-obstructing stone in the right renal lower calyx with a density of 700 Hounsfield Units (HU) indicated for Extracorporeal Shock Wave Lithotripsy (ESWL)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of a 0.7 cm Non-Obstructing Lower Caliceal Renal Stone with 700 HU Density

For a 0.7 cm non-obstructing lower caliceal stone with a density of 700 HU, Extracorporeal Shock Wave Lithotripsy (ESWL) is an appropriate first-line treatment option. 1, 2

Treatment Decision Factors

Stone Characteristics Supporting ESWL:

  • Size: At 0.7 cm (<10 mm), this stone falls within the size range where ESWL is recommended as a first-line option 1, 2
  • Location: While lower pole location reduces ESWL efficacy compared to other locations, for stones ≤10 mm, ESWL remains a viable first-line option 1
  • Density: At 700 HU, this stone has a density that is within the acceptable range for ESWL treatment 3
  • Non-obstructing nature: The absence of obstruction is favorable for ESWL treatment 1

Evidence-Based Treatment Algorithm:

  1. For lower pole stones ≤10 mm: Both ESWL and URS (Ureteroscopy) are recommended first-line options 1, 2

    • Stone-free rates for ESWL in this scenario are acceptable 1
    • The AUA/Endourological Society guidelines specifically support either ESWL or URS for symptomatic lower pole renal stones ≤10 mm (Strong Recommendation; Evidence Strength: Grade B) 1
  2. Stone density considerations:

    • While 700 HU is moderately dense, it remains below the critical threshold of 970 HU identified by research as a cutoff above which ESWL success rates significantly decrease 3
    • For stones <970 HU, the stone-free rate with ESWL has been reported at 96% 3

Procedural Considerations for ESWL

  • Pre-procedure preparation:

    • Routine stenting should not be performed before ESWL 1
    • Adequate imaging (typically non-contrast CT) should be available to guide treatment 1
  • Post-procedure management:

    • Consider prescribing α-blockers after ESWL to facilitate passage of stone fragments 1, 2
    • Follow-up imaging is necessary to confirm stone clearance 2

Alternative Treatment Option

If ESWL is not preferred or fails, URS should be considered as the alternative first-line treatment:

  • URS offers a higher stone-free rate in a single procedure compared to ESWL 1
  • URS is less affected by stone composition and density 1
  • URS may be particularly beneficial if the patient has unfavorable factors for ESWL success (e.g., steep infundibular-pelvic angle, long lower pole calyx) 2

Important Caveats

  • ESWL limitations: Success rates for ESWL are influenced by:

    • Stone composition (cystine stones respond poorly to ESWL) 1
    • Patient factors such as obesity and skin-to-stone distance 1
    • Collecting system anatomy 1
  • Treatment failure: If initial ESWL fails, an endoscopic approach (URS) is recommended 1

  • Contraindications to consider: ESWL may be contraindicated in patients with:

    • Pregnancy
    • Uncontrolled coagulopathy
    • Uncontrolled urinary tract infection
    • Anatomical obstruction distal to the stone 1

In summary, for this 0.7 cm non-obstructing lower caliceal stone with 700 HU density, ESWL is an appropriate first-line treatment with good expected outcomes based on the stone's characteristics.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.